NAXS AB ( ($SE:NAXS) ) just unveiled an update. NAXS AB has repurchased 4,329 of its own shares on Nasdaq Stockholm between 18 and 22 May 2026 as p......

Axis Capital ( ($AXS) ) just unveiled an announcement. At its Annual General Meeting of Shareholders held on May 14, 2026, AXIS Capital shareholder......

NAXS AB ( ($SE:NAXS) ) has issued an update. NAXS AB has continued its share repurchase program, buying back 4,029 shares on Nasdaq Stockholm betwe......

The latest announcement is out from NAXS AB ( ($SE:NAXS) ). NAXS AB has repurchased 3,970 of its own shares on Nasdaq Stockholm between 4 and 8 May......

Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on Axsome Therapeutics today and set a price target of $310.00. Suvannavejh cov......

Morgan Stanley analyst Sean Laaman maintained a Hold rating on Axsome Therapeutics today and set a price target of $242.00. According to TipRanks, ......

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Travere Therapeutics (TVTX) and Axsome Therapeutics ......

Axsome Therapeutics Inc. (($AXSM)) has held its Q1 earnings call. Read on for the main highlights of the call. Axsome Therapeutics Inc. struck an u......

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Evotec AG (EVO), Twist Bioscience (TWST) and Axsome ......

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Arvinas Holding Company (ARVN) and Axsome Therapeuti......